PLLA Skin Regeneration Injectable is a lyophilized injectable based on poly-L-lactic acid (PLLA), developed for aesthetic applications where gradual collagen stimulation and tissue rejuvenation are required.
Unlike conventional gel fillers that primarily provide immediate volume, PLLA-based injectables are used as collagen-stimulating products. The formulation, PLLA content, particle characteristics, reconstitution behavior, and injection protocol are critical to product performance and batch consistency.
Product
|
Parameter |
Specification |
|
Product Name |
PLLA Skin Regeneration Injectable |
|
Active Material |
Poly-L-Lactic Acid (PLLA) |
|
Dosage Form |
Lyophilized powder |
|
Packaging |
Sterile vial |
|
Intended Use |
Aesthetic skin and tissue rejuvenation |
|
Main Mechanism |
Collagen stimulation |
|
Application |
Face and selected body areas, according to product registration and instructions for use |
|
Shelf Life |
2 years* |
|
Storage |
Room temperature* |
|
Supply Model |
OEM / Private Label / Distributor Supply |
Key Product Characteristics
Lyophilized Injectable Format
The product is supplied as a freeze-dried powder in a sterile vial. Lyophilization provides a dry formulation format suitable for products requiring controlled storage and reconstitution before use. Procurement evaluation includes:
- Lyophilization process parameters
- Cake appearance and integrity
- Residual moisture
- Reconstitution characteristics
- Vial closure integrity
- Sterility assurance
PLLA as the Functional Material
PLLA is the principal material responsible for the collagen-stimulating function. Material characteristics include:
Polymer quality
Molecular characteristics
Particle morphology
Particle-size distribution
Surface characteristics
Material purity
Batch-to-batch consistency
Controlled Formulation
A PLLA injectable requires precise control over carrier components, powder structure, and manufacturing parameters. These factors determine dispersion, handling, and batch consistency during clinical use.
Application Areas
Subject to applicable product registration, labeling, and instructions for use, PLLA injectable products may be positioned for aesthetic applications involving:
Facial Rejuvenation: Treatment protocols where gradual improvement in skin quality, firmness, and tissue structure is desired.
Facial Volume-Related Indications: Aesthetic treatment plans involving gradual restoration of tissue volume.
Skin Quality Improvement: Programs focused on skin firmness, elasticity, and overall tissue quality via collagen stimulation.
Selected Body Applications: Non-facial aesthetic applications, dependent on registered indications and market-specific instructions.
Product Selection Guide
Different PLLA products should not be selected by active-material weight alone.
Evaluate PLLA Content: Compare total PLLA content per vial alongside the complete formulation and intended indication.
Review Particle Characteristics: Verify particle-size distribution, morphology, uniformity, and test methods with the manufacturer.
Check Reconstitution Requirements: Review recommended diluents, reconstitution volume, time limits, and handling procedures from validated product instructions.
Verify Intended Treatment Layer: Confirm injection depth, anatomical indications, and technique alignment with destination market regulations.
Manufacturing and Quality Control
The production system for PLLA injectable products includes documented controls covering:
Raw Material Control: Incoming materials evaluated against defined specifications for identity, purity, physical characteristics, and supplier qualification.
Formulation Control: Critical production parameters controlled, including material weighing, homogenization, filling accuracy, and lyophilization cycles.
Sterile Product Control: Vials supported by bioburden testing, sterility validation, container closure integrity, particulate matter limits, and environmental monitoring.
Finished Product Testing: Verification of appearance, fill weight, active material content, reconstitution behavior, sterility, bacterial endotoxins, and stability.
Manufacturing Capability for OEM and Private Label
Technical review for OEM or private-label PLLA projects covers:
Product Configuration: PLLA content, vial configuration, packaging format, label information, product naming, and IFU requirements.
Private-Label Packaging: Customized labels, brand artwork, outer carton design, and market-specific labeling.
Documentation Support: Product specifications, Certificates of Analysis (CoA), material documentation, stability data, sterilization records, quality-system documentation, and technical files for the destination market.
FAQ
Q: What is a PLLA skin regeneration injectable?
A: It is an injectable product based on poly-L-lactic acid (PLLA), generally positioned for collagen stimulation and gradual aesthetic tissue rejuvenation.
Q: Is PLLA the same as a hyaluronic acid filler?
A: No. PLLA is primarily positioned as a collagen-stimulating material, while HA fillers are gel-based products commonly used for immediate volume restoration.
Q: What form is the PLLA product supplied in?
A: The PLLA products are supplied as lyophilized powder in sterile vials.
Q: What does the 405 mg PLLA formulation contain?
A: The listed 405 mg formulation contains poly-L-lactic acid, carboxymethyl cellulose, and mannitol.
Q: Does PLLA require reconstitution before injection?
A: Yes. A lyophilized PLLA formulation requires reconstitution according to validated instructions for use.
Q: How long can PLLA products be stored?
A: The product information lists a 2-year shelf life. Applicable storage conditions should be confirmed against product specifications for the specific SKU.
Q: Can the PLLA product be supplied under a private label?
A: OEM supply options are available for PLLA products. Private-label configuration, MOQ, and documentation requirements must be confirmed according to the target market.
Q: What documents should I request before placing an order?
A: Request product specifications, CoA, regulatory documentation, quality certificates, stability information, packaging specifications, and applicable sterilization documentation.
Q: Can you provide samples?
A: Sample availability is confirmed based on requested formulations, destination markets, and shipping requirements.
Hot Tags: plla skin regeneration injectable, China plla skin regeneration injectable manufacturers, suppliers, factory
